Back to Results
First PageMeta Content



Clementia Pharmaceuticals Announces Open-Label Phase 2 Extension Study of Palovarotene in Patients with Fibrodysplasia Ossificans Progressiva
Add to Reading List

Document Date: 2014-10-27 07:37:13

Open Document

File Size: 330,65 KB

Share Result on Facebook
UPDATE